Clinical Trial Update: A Study of Volociximab in Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 study of volociximab in Stage IV melanoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Volociximab (volociximab)

Snippet

Sponsor: Abbott | Conditions: Stage IV Melanoma | Phase 2 | Status: TERMINATED